The MHRA has released its business plan for 2014-2015 as of mid-April. The “key strategic activities” section of the plan shows an emphasis on surveillance as well as on increasing collaboration with other regulators to better ensure the quality of medicinal products.
[/membership][membership level=”0,4″][The content continues for paid members only.]
Login or Subscribe [/membership][membership level=”1,5,6,7,8,9,10,11,12″][membership]
